Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Functional Fas (Cd95/Apo-1) promoter polymorphisms in inbred mouse strains exhibiting different susceptibility to γ-radiation-induced thymic lymphoma

Abstract

The Fas death receptor is a cell surface molecule involved in apoptosis as well as in proliferative or activating signals of many cells types, including T lymphocytes. Using quantitative real-time reverse transcription–PCR analysis, we confirm that expression of this gene is scarcely perceptible in thymic lymphomas induced by γ-irradiation in C57BL/6J mice. Notably, we also demonstrate for the first time that Fas expression is significantly upregulated in vivo both after single high dose of radiation and in thymic lymphoma-free mice. In addition, we determined its levels of expression in five mouse strains exhibiting different degrees of susceptibility (SPRET/Ei, SEG/Pas, BALB/cJ, C57BL/6J and RF/J). Interestingly, we found the highest levels of expression in SPRET/Ei and SEG/Pas strains (both derived from the Mus spretus species), which are known to have the most resistant phenotype, and the lowest levels in the most susceptible strains C57BL/6J and RF/J. DNA sequencing of the Fas promoter in all five strains showed many polymorphisms that can be classified into three functional haplotypes by using luciferase assays: (1) C57BL/6J and RF/J, (2) BALB/cJ and (3) SPRET/Ei and SEG/Pas. Promoter activities in response to single high doses of radiation correlated well with the levels of Fas expression and are consistent with the degree of strain susceptibility.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  • Adachi M, Suematsu S, Suda T, Watanabe D, Fukuyama H, Ogasawara J et al. (1996). Proc Natls Acad Sci USA 93: 2131–2136.

  • Booker JK, Reap EA, Cohen PL . (1998). J Immunol 161: 4536–4541.

  • Castro JE, Listman JA, Jacobson BA, Wang Y, López PA, Ju S et al. (1996). Immunity 5: 617–627.

  • Chan H, Bartos DP, Owen-Schaub LB . (1999). Mol Cell Biol 19: 2098–2108.

  • DeRyckere D, Mann DL, DeGregory J . (2003). J Immunol 171: 802–811.

  • Feuk L, Prince JA, Blennow K, Brookes AJ . (2003). Hum Mutat 21: 53–60.

  • Fleck M, Zhou T, Tatsuta T, Yang P, Wang P, Mountz JD . (1998). J Immunol 160: 3766–3775.

  • Hettmann T, DiDonato J, Karin M, Leiden JM . (1999). J Exp Med 189: 145–157.

  • Hettmann T, Leiden JM . (2000). J Immunol 165: 5004–5010.

  • Hoogendoorn B, Coleman SL, Guy CA, Smith K, Bowen T, Buckland PR et al. (2003). Hum Mol Genet 12: 2249–2254.

  • Kishimoto H, Surh CD, Sprent J . (1998). J Exp Med 187: 1427–1438.

  • Krammer PH . (2000). Nature 407: 789–795.

  • Kurasawa K, Hashimoto Y, Iwamoto I . (1999). Cell Immunol 194: 127–135.

  • Lai HC, Sytwu HK, Sun CA, Yu MH, Yu CP, Liu HS et al. (2003). Int J Cancer 103: 221–225.

  • Maas K, Westfall M, Pietenpol J, Olsen NJ, Aune T . (2005). Arthritis Rheumatism 52: 1047–1057.

  • Meléndez B, Santos J, Fernández-Piqueras J . (1999). Oncogene 18: 4166–4169.

  • Muschen M, Warskulat U, Beckann MW . (2000). J Mol Med 78: 312–325.

  • Nagata S, Suda T . (1995). Immunol Today 16: 39–43.

  • Nishimura Y, Ishii A, Kobayashi Y, Yamasaki Y, Yonehara S . (1995). J Immunol 154: 4395–4403.

  • Ogasawara J, Suda T, Nagata S . (1995). J Exp Med 181: 485–491.

  • Oukka M, Ho C, de la Brousse FC, Hoey T, Grusby MJ, Glimcher LH . (1998). Immunity 9: 295–304.

  • Pinkoski MJ, Green DR . (1999). Cell Death Differ 6: 1174–1181.

  • Rathmell JC, Thompson CB . (2002). Cell 109: S97–S107.

  • Reap EA, Roof K, Maynor K, Borrero M, Booker J, Cohen PL . (1997). Proc Natl Acad Sci USA 94: 5750–5755.

  • Santos J, Herranz M, Fernández M, Vaquero C, López P, Fernández-Piqueras J . (2001). Oncogene 20: 2186–2189.

  • Santos J, Montagutelli X, Acevedo A, López P, Vaquero C, Fernández M et al. (2002). Oncogene 21: 6680–6683.

  • Santos J, Pérez de Castro I, Herranz M, Pellicer A, Fernández-Piqueras J . (1996). Oncogene 12: 669–676.

  • Schmitz I, Clayton LK, Reinherz EL . (2003). Int Immunol 15: 1237–1248.

  • Sibley K, Rollinson S, Allan JM, Smith AG, Law GR, Roddam PL et al. (2003). Cancer Res 63: 4327–4330.

  • Siegel RM, Chan KM, Chun HJ, Lebardo MJ . (2000). Nat Immunol 1: 469–474.

  • Zheng Y, Ouaaz F, Bruzzo P, Singh V, Gerondakis S, Beg AA . (2001). J Immunol 166: 4949–4957.

Download references

Acknowledgements

We thank L González, M Matabuena, M Guerrero, MJ Bueno and R Peregil for aid with animals, P Fernández for helping with statistical analysis and E Pérez-Gómez for technical assistance. We are also grateful to Professor A Morales for critical reading of the manuscript. This work was supported by grants from the European Commission (EURATOM Work Programme 2003, FI6R-CT-2003-508842 to JS), ‘Ministerio de Educación y Ciencia’ (SAF2003-05048) and ‘Ministerio de Salud y Consumo’ (Lymphoma Network, G03/179) to JF-P. MV-M is the recipient of a predoctoral fellowship from ‘Ministerio de Educación y Ciencia’ (FPU AP2002-0294).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J Fernández-Piqueras.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Villa-Morales, M., Santos, J. & Fernández-Piqueras, J. Functional Fas (Cd95/Apo-1) promoter polymorphisms in inbred mouse strains exhibiting different susceptibility to γ-radiation-induced thymic lymphoma. Oncogene 25, 2022–2029 (2006). https://doi.org/10.1038/sj.onc.1209234

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209234

Keywords

This article is cited by

Search

Quick links